首页> 外文期刊>Clinical ophthalmology >Survey of intravitreal injection techniques among retina specialists in Israel
【24h】

Survey of intravitreal injection techniques among retina specialists in Israel

机译:以色列视网膜专家中玻璃体内注射技术调查

获取原文
           

摘要

Purpose: The purpose of this study was to describe antivascular endothelial growth factor intravitreal injection techniques of retinal specialists in order to establish a cornerstone for future practice guidelines. Methods : All members of the Israeli Retina Society were contacted by email to complete an anonymous, 19-question, Internet-based survey regarding their intravitreal injection techniques. Results: Overall, 66% (52/79) completed the survey. Most (98%) do not instruct patients to discontinue anticoagulant therapy and 92% prescribe treatment for patients in the waiting room. Three quarters wear sterile gloves and prepare the patient in the supine position. A majority (71%) use?sterile surgical draping. All respondents apply topical analgesics and a majority (69%) measure the distance from the limbus to the injection site. A minority (21%) displace the conjunctiva prior to injection. A majority of the survey participants use a 30-gauge needle and the most common quadrant for injection is superotemporal (33%). Less than half routinely assess postinjection optic nerve perfusion (44%). A majority (92%) apply prophylactic antibiotics immediately after the injection. Conclusion: The majority of retina specialists perform intravitreal injections similarly. However, a relatively large minority performs this procedure differently. Due to the extremely low percentage of complications, it seems as though such differences do not increase the risk. However, more evidence-based medicine, a cornerstone for practice guidelines, is required in order to identify the intravitreal injection techniques that combine safety and efficacy while causing as little discomfort to the patients as possible.
机译:目的:本研究的目的是描述视网膜专家玻璃体内注射技术的抗病毒内皮生长因子,以建立未来实践指南的基石。方法:通过电子邮件联系以色列视网膜社会的所有成员,以完成关于其玻璃体内注射技术的匿名,19个问题的互联网的调查。结果:总体而言,66%(52/79)完成了调查。大多数(98%)不要指导患者停止抗凝治疗和92%的候诊室患者的疗法治疗。三个季度穿着无菌手套,并在仰卧位准备患者。大多数(71%)使用?无菌手术垂直。所有受访者都适用局部镇痛药,大多数(69%)衡量与林实林斯到注射部位的距离。少数群体(21%)在注射之前置换结膜。大多数调查参与者使用30·仪表针,最常见的注射象限是卓越运动型(33%)。不到一半常规地评估乳房射击视神经灌注(44%)。大多数(92%)在注射后立即施加预防性抗生素。结论:大多数视网膜专家同样进行玻璃体内注射。但是,相对较大的少数群体不同地执行此程序。由于并发症的百分比极低,似乎如此差异不会增加风险。然而,需要更多的循证医学,是实践指导方针的基石,以确定与玻璃体内注射技术相结合的玻璃体内注射技术,这些技术结合了安全性和疗效,同时导致尽可能少的患者的不适。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号